Search for: "Sirna "
Results 1 - 20
of 42
Sorted by Relevance
|
Sort by Date
22 Oct 2022, 8:06 pm
J A Kemp will be offering a webinar entitled "siRNA inventions at the EPO" on October 27, 2022 from 16:00 pm to 17:00 pm (GMT). [read post]
13 Sep 2021, 4:15 am
Rational siRNA design and delivery methods have significantly improved their stability, limited immune activation, and increased target affinity resulting in an influx of siRNA-based clinical trials. [read post]
3 Aug 2009, 8:26 pm
., 2009, "Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein," Nature Biotechnology 27: 567-71) describes a new system for introducing short interfering RNAs (siRNAs) into mammalian cells that may help this technology become practicable for therapeutic uses. [read post]
13 Sep 2021, 4:15 am
Rational siRNA design and delivery methods have significantly improved their stability, limited immune activation, and increased target affinity resulting in an influx of siRNA-based clinical trials. [read post]
6 Jul 2011, 11:31 am
FASTER, PLEASE: Stroke prevention and recovery with nanotube-delivered siRNA. [read post]
9 Jan 2008, 9:48 pm
According to the statement released by Proteologics, the '227 patent encompasses siRNA molecules that inhibit the... [read post]
8 Oct 2007, 3:37 pm
The Sirna v. [read post]
16 Sep 2008, 4:55 am
Patent No. 7,422,896, which is directed to DNA compositions that mediate RNA interference (RNAi) gene silencing, wherein the DNA compositions include an RNA polymerase III promoter that drives the expression of a nucleotide sequence encoding an intermediate small interfering RNA (siRNA) molecule, and RNA polymerase III terminator. [read post]
23 Jul 2015, 8:30 am
Claim 85 recites a method of rationally designing siRNA molecules with optimal suppression... [read post]
26 Nov 2020, 9:00 pm
CompanyPolyplus-transfection is a biotechnology company that develops, markets and sells innovative solutions for the delivery of nucleic acids in research, bio-production and therapeutics.Polyplus-transfection supplies its proprietary range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network since 2001. [read post]
31 Oct 2006, 3:52 am
Merck & Company will pay $1.1 billion to acquire Sirna Therapeutics, one of the leading companies pursuing the technology that was the basis for the Nobel Prize in medicine awarded earlier this month. [read post]
29 Apr 2021, 10:45 am
., a Gaithersburg-based biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer, fibrotic diseases and viral infections, Thursday announced the company has entered into a partnership agreement with Walvax Biotechnology for the co-development of its anti-influenza siRNA therapeutic product candidate STP702. [read post]
15 Jul 2008, 4:57 am
The patent was opposed by several companies involved in commercializing RNA interference (RNAi), including Sanofi-Aventis Deutschland GmbH, Sirna Therapeutics, Nucleonics, Inc., Quark Biotech, and Silence Therapeutics AG. [read post]
23 Oct 2022, 8:20 pm
Patent and Trademark Office) - 10:00 am to 11:00 am (ET) October 27, 2022 - "siRNA inventions at the EPO" (J A Kemp) - 16:00 pm to 17:00 pm (GMT) October 27, 2022 - "UPC: The Countdown Begins! [read post]
8 Mar 2007, 8:18 am
Sirna's Senior Scientist, J.A. [read post]
5 Feb 2014, 9:52 am
The FTC alleged that the combined company would have a share of more than 50 percent of the worldwide market for individual siRNA reagents, and greater than 90 percent of the market for siRNA reagent libraries. [read post]
13 Jul 2020, 6:53 am
Steven Dowdy at UC San Diego was awarded $150,000 to study a more effective way of delivering a genetic medicine, called siRNA, into the lungs of infected patients.Summaries of the CIRM application review on the grants can be found here, including the six rejected. [read post]
5 Sep 2008, 4:52 am
Isis noted that the two allowed applications are directed to methods of treating patients by administering an siRNA... [read post]
20 Mar 2012, 3:49 pm
More specifically, the "Zamore Design Rule" patents describe methods of enhancing the ability of an antisense strand of an RNAi agent to act as a guide strand; codify RNAi and siRNA agents for enhancing silencing of a target mRNA in an organism; and cover the composition of siRNA duplexes, pre-miRNA and shRNA in the process of RNA interference. [read post]
3 Aug 2011, 5:11 am
And, yes, there is a patent story related to Sirna. [read post]
